Moreover, c-KIT-R tyrosine kinase inhibitors are used for evaluative clinical trials in humans in gastrointestinal stromal tumor (GIST), mastocytosis, and pancreatic cancer [143]. The gene discussed is KIT; the disease is gastrointestinal stromal tumor.